Neurosterix

Series-B
neurosterix.com Biotech & Healthcare
Total Funding $168M
Latest Round $105M Series-B
Last Announced Nov 13, 2026
Investors 5 Backers
Decision Makers Profile Active

About Neurosterix

Harnessing the power of allosteric modulators to design targeted, next-generation therapies for complex neuropsychiatric disorders.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Undisclosed
Tracked Since Nov 13, 2026

Web & Domain Identity

Official Website neurosterix.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @neurosterix
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $105,000,000 · Series-B

    Backed by RTW Investments

  2. Capital Raise

    Raised $63,000,000 · Series-A

    Backed by Perceptive Advisors

Investors & Backers

5
Perceptive Advisors
Lead
RTW Investments
Lead
Acorn Bioventures
Addex Therapeutics
Xontogeny

Funding History

2 Rounds
Series-B equity · Nov 13, 2026

Round backers: RTW Investments

$105,000,000 citybiz.co
Series-A equity · Apr 3, 2024

Round backers: Perceptive Advisors

$63,000,000 xontogeny.com

Founders & Leadership

2

Fred Callori

CEO, Co-Founder, Board of Directors

Work email & phone locked Unlock →

Mikhail Kalinichev

Head of Translational Science

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts